By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Caliper Life Sciences today reported that its third-quarter revenues increased 24 percent year over year, or 16 percent organically, with strong growth for its LabChip, imaging, and research products.

The Hopkinton, Mass.-based firm brought in total revenues of $36.9 million for the three-month period ended Sept. 30, compared to $29.7 million for the third quarter of 2010. It beat the Wall Street consensus estimate of $35.6 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.

Adam Rutherford discusses genetic genealogy at the Guardian.

Portions of the US 21st Century Cures Act are raising some safety concerns.

David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.